CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity

DNA methylation is an epigenetic modification of the mammalian genome that occurs predominantly at cytosine residues of the CpG dinucleotide. Following formaldehyde activation, pixantrone alkylates DNA and particularly favours the CpG motif. Aberrations in CpG methylation patterns are a feature of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Evison, Benny J., Bilardi, Rebecca A., Chiu, Francis C. K., Pezzoni, Gabriella, Phillips, Don R., Cutts, Suzanne M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Gene Regulation, Chromatin and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770666/
https://www.ncbi.nlm.nih.gov/pubmed/19720735
http://dx.doi.org/10.1093/nar/gkp700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770666/
https://www.ncbi.nlm.nih.gov/pubmed/19720735
http://dx.doi.org/10.1093/nar/gkp700

Ejemplares similares